Acetylcysteine seems to be beneficial in treating cystinuric stone-forming patients. It probably is effective in reducing cysteine to cystine disulfide, which is more soluble. Six brief case reports demonstrate its use and its lack of toxicity. The results merit a larger clinical trial.
The first reported case of bilateral, simultaneous renal tumors of dissimilar cell type treated in a living patient is presented. The operative approach is outlined to support single in situ operative procedures in young patients. A second look laparotomy at 1 year and a creatinine clearance of 60 ml. per minute at 2 years substantiate our enthusiasm for this approach to bilateral renal lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.